Jump to the top of the page

Showing 1120 – 1130 of 1307 results

  • Tarsus Pharmaceuticals Inc Initiation

    William Blair initiated research coverage of Tarsus Pharmaceuticals, Inc. (TARS $17.65), a development-stage biopharmaceutical company focused on therapies that address large market opportunities in ophthalmic conditions with limited treatment options.

  • TransMedics Group Inc Initiation

    William Blair initiated research coverage of TransMedics Group, Inc. (TMDX $94.04), the leading provider of organ care systems for end-stage organ failure patients across multiple disease states.

  • Arcturus Therapeutics Holdings Inc Initiation

    William Blair initiated research coverage of Arcturus Therapeutics Holdings Inc. (ARCT $35.50), a company focused on creating mRNA vaccines and therapies using its proprietary LUNAR mRNA- LNP technologies.

  • WillScot Mobile Mini Holdings Corp

    William Blair initiated research coverage of WillScot Mobile Mini Holdings Corp. (WSC $48.20), a leading commercial logistics provider of modular and storage solutions.

  • Avid Bioservices Inc Initiation

    William Blair initiated research coverage of Avid Bioservices, Inc. (CDMO $10.01), a contract development and manufacturing organization (CDMO) focused on biologics drug substance manufacturing.

  • The Trade Desk Inc Initiation

    William Blair initiated research coverage of The Trade Desk, Inc. (TTD $79.93), a company providing programmatic marketing automation technologies, services, and products.

  • Intuitive Surgical Inc Initiation

    William Blair initiated research coverage of Intuitive Surgical, Inc. (ISRG $246.68), which offers an ecosystem of minimally invasive surgical products and services that are founded on its da Vinci robotic system.

  • Pegasystems Inc Initiation

    William Blair initiated research coverage of Pegasystems Inc. (PEGA $47.27), a leading provider of intelligent automation and customer engagement software solutions for enterprise customers.

  • CymaBay Therapeutics Inc Initiation

    William Blair initiated research coverage of CymaBay Therapeutics, Inc. (CBAY $8.66), a clinical-stage biotechnology company that is developing therapeutics for liver and other chronic diseases.

  • Paycor HCM Inc Initiation

    William Blair initiated research coverage of Paycor HCM, Inc. (PYCR $26.52), a cloud human capital management (HCM) provider that targets businesses with 10 to 1,000 employees.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures